157 related articles for article (PubMed ID: 31870729)
1. Time-driven activity-based costing of adjuvant vaginal cuff brachytherapy for uterine cancer in an integrated brachytherapy suite.
Su L; Dutta SW; Sanders JC; Wu T; Libby B; Romano KD; Showalter TN
Brachytherapy; 2020; 19(2):176-180. PubMed ID: 31870729
[TBL] [Abstract][Full Text] [Related]
2. Quantifying institutional resource utilization of adjuvant brachytherapy and intensity-modulated radiation therapy for endometrial cancer via time-driven activity-based costing.
Ning MS; Klopp AH; Jhingran A; Lin LL; Eifel PJ; Vedam S; Lawyer AA; Olivieri ND; Guzman AB; Incalcaterra JR; Mesko SM; Pezzi TA; Boyce-Fappiano DR; Shaitelman SF; Frank SJ; Thaker NG
Brachytherapy; 2019; 18(4):445-452. PubMed ID: 30992185
[TBL] [Abstract][Full Text] [Related]
3. Economic impact of decreasing the fraction number in vaginal cuff brachytherapy: A direct cost analysis.
Zhang Y; Rovirosa A; Ascaso C; Herreros A; Torne A; Li Y; Biete A; Sánchez J
Brachytherapy; 2020; 19(1):60-65. PubMed ID: 31587986
[TBL] [Abstract][Full Text] [Related]
4. Time-driven activity-based costing of a novel form of CT-guided high-dose-rate brachytherapy intraoperative radiation therapy compared with conventional breast intraoperative radiation therapy for early stage breast cancer.
Suralik G; Rudra S; Dutta SW; Yu J; Sanders JC; Schad MD; Janowski EM; Su L; Libby B; Showalter SL; Lobo JM; Showalter TN
Brachytherapy; 2020; 19(3):348-354. PubMed ID: 32229072
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Delivery Costs for External Beam Radiation Therapy and Brachytherapy for Locally Advanced Cervical Cancer Using Time-Driven Activity-Based Costing.
Bauer-Nilsen K; Hill C; Trifiletti DM; Libby B; Lash DH; Lain M; Christodoulou D; Hodge C; Showalter TN
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):88-94. PubMed ID: 29079120
[TBL] [Abstract][Full Text] [Related]
6. A comparative study using time-driven activity-based costing in single-fraction breast high-dose rate brachytherapy: An integrated brachytherapy suite vs. decentralized workflow.
Squeo GC; Lattimore CM; Simone NL; Suralik G; Dutta SW; Schad MD; Su L; Libby B; Janowski EM; Showalter SL; Lobo JM; Showalter TN
Brachytherapy; 2022; 21(3):334-340. PubMed ID: 35125328
[TBL] [Abstract][Full Text] [Related]
7. Developing an intraoperative 3T MRI-guided brachytherapy program within a diagnostic imaging suite: Methods, process workflow, and value-based analysis.
Ning MS; Venkatesan AM; Stafford RJ; Bui TP; Carlson R; Bailard NS; Vedam S; Davis R; Olivieri ND; Guzman AB; Incalcaterra JR; McKelvey FA; Thaker NG; Rauch GM; Tang C; Frank SJ; Joyner MM; Lin LL; Jhingran A; Eifel PJ; Klopp AH
Brachytherapy; 2020; 19(4):427-437. PubMed ID: 31786169
[TBL] [Abstract][Full Text] [Related]
8. Time-driven activity-based cost comparison of prostate cancer brachytherapy and intensity-modulated radiation therapy.
Dutta SW; Bauer-Nilsen K; Sanders JC; Trifiletti DM; Libby B; Lash DH; Lain M; Christodoulou D; Hodge C; Showalter TN
Brachytherapy; 2018; 17(3):556-563. PubMed ID: 29519605
[TBL] [Abstract][Full Text] [Related]
9. Impact of different adjuvant radiotherapy modalities on women with early-stage intermediate- to high-risk endometrial cancer.
Jin M; Hou X; Sun X; Zhang Y; Hu K; Zhang F
Int J Gynecol Cancer; 2019 Oct; 29(8):1264-1270. PubMed ID: 31320487
[TBL] [Abstract][Full Text] [Related]
10. Comparing organ-at-risk doses for high-dose-rate vaginal brachytherapy between three different planning workflows.
Gruhl JD; Zheng D; Longo JL; Enke C; Wahl AO
Brachytherapy; 2017; 16(2):373-377. PubMed ID: 28039010
[TBL] [Abstract][Full Text] [Related]
11. A Medicare cost analysis of MRI- versus CT-based high-dose-rate brachytherapy of the cervix: Can MRI-based planning be less costly?
Bajaj A; Harmon G; Weaver J; Martin B; Mysz M; Surucu M; Roeske JC; Konski AA; Small W; Harkenrider MM
Brachytherapy; 2018; 17(2):326-333. PubMed ID: 29331574
[TBL] [Abstract][Full Text] [Related]
12. Vaginal cuff brachytherapy for endometrial cancer: a review of major clinical trials with a focus on fractionation.
Parsons MW; Huang YJ; Burt L; Suneja G; Gaffney D
Int J Gynecol Cancer; 2022 Mar; 32(3):311-315. PubMed ID: 35256417
[TBL] [Abstract][Full Text] [Related]
13. Single or multi-channel vaginal cuff high-dose-rate brachytherapy: Is replanning necessary prior to each fraction?
Zhou J; Prisciandaro J; Lee C; Schipper M; Eisbruch A; Jolly S
Pract Radiat Oncol; 2014; 4(1):20-6. PubMed ID: 24621419
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric effects of air pockets around high-dose rate brachytherapy vaginal cylinders.
Richardson S; Palaniswaamy G; Grigsby PW
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):276-9. PubMed ID: 20395068
[TBL] [Abstract][Full Text] [Related]
15. Vaginal brachytherapy for postoperative endometrial cancer: 2014 Survey of the American Brachytherapy Society.
Harkenrider MM; Grover S; Erickson BA; Viswanathan AN; Small C; Kliethermes S; Small W
Brachytherapy; 2016; 15(1):23-9. PubMed ID: 26620818
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional treatment planning for vaginal cuff brachytherapy: dosimetric effects on organs at risk according to patients position.
Iatì G; Pontoriero A; Mondello S; Brogna A; Di Pasquale A; Ielo I; Potami A; Messina G; De Renzis C; Pergolizzi S
Brachytherapy; 2014; 13(6):568-71. PubMed ID: 24986362
[TBL] [Abstract][Full Text] [Related]
17. Comparative results of three short brachytherapy schedules as exclusive treatment in postoperative endometrial carcinoma.
Rovirosa Á; Herreros A; Camacho C; Ascaso C; Sánchez J; Cortés S; Sabater S; Solà J; Torné A; Arenas M
Brachytherapy; 2017; 16(6):1169-1174. PubMed ID: 28801116
[TBL] [Abstract][Full Text] [Related]
18. Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer?
Ager BJ; Francis SR; Do OA; Huang YJ; Soisson AP; Dodson MK; Werner TL; Sause WT; Grant JD; Gaffney DK
Brachytherapy; 2019; 18(4):453-461. PubMed ID: 31005603
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of adjuvant intravaginal brachytherapy in high-intermediate risk endometrial carcinoma.
Stahl JM; Damast S; Bledsoe TJ; An Y; Verma V; Yu JB; Young MR; Lester-Coll NH
Brachytherapy; 2018; 17(2):399-406. PubMed ID: 29275078
[TBL] [Abstract][Full Text] [Related]
20. Salvage high-dose-rate brachytherapy and external beam radiotherapy for isolated vaginal recurrences of endometrial cancer with no prior adjuvant therapy.
Chapman CH; Maghsoudi K; Littell RD; Chen LM; Hsu IC
Brachytherapy; 2017; 16(6):1152-1158. PubMed ID: 28802913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
